Nonselective Beta-Blockers May Improve Outcomes in Ovarian Cancer
August 29, 2022 2:19 pmby Charles Bankhead
Women with cardiovascular conditions (CVCs) and ovarian cancer had better 2-year survival if they received a nonselective beta blocker (NSBB) at or around the time of cancer surgery, a review of medical records showed.
Two-year postoperative survival … Read more